Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON41137
NL-OMON41137
Completed
Not Applicable

Imaging of Ventricular Reversed Remodeling after Double Lung Transplantation in Patients with Pulmonary Arterial Hypertension - Ventricular reversed remodeling after LTX in patients with PAH

niversitair Medisch Centrum Groningen0 sites20 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionshigh blood pressure pulmonary arteryIdiopathic/primary pulmonary arterial hypertension1001928010037454

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
high blood pressure pulmonary artery
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
20
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Primary study group:
  • •\- Patients who are on the waiting list for double\-LTX, in our institution, for pulmonary arterial hypertension
  • •\- Eligible for CMR imaging
  • •\- No claustrophobia
  • •\- No pacemaker, ICD, etc.
  • •\- Informed consent;Control group:
  • •\- Patients who are on the waiting list for double\-LTX, in our institution.
  • •\- Echocardiographic evaluation including an estimation of RV peak pressure, \<35 mmHg.
  • •\- Eligible for CMR imaging
  • •\- No claustrophobia

Exclusion Criteria

  • •\- Inability to comply with primary endpoint measures.
  • •\- Body mass index \>40 kg/m2\.
  • •\- Pregnant patients will not be included, they may be included \>3 months after pregnancy.
  • •\- Patients with age \<18 years

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
eft ventricular reverse remodelling after aortic valve replacement in severe valvular aortic stenosis - effect of blockade of the angiotensin-II receptorPatients with severe aortic valve stenosis treated with Aortic Valve Replacement (AVR)
EUCTR2005-001930-34-DKDepartment of Cardiology, Odense University Hospital
Active, not recruiting
Phase 1
Right ventriculAr reverse reModeling and hemodynamic improvement after add-on combination therapy (ambriSentan/PDE-5i) in PAH patientS (RAMSES)patients with pulmonary arterial hypertentionMedDRA version: 21.1Level: PTClassification code 10037400Term: Pulmonary hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2016-004806-32-ITITALIAN PULMONARY HYPERTENSION NETWORK, IPHNET54
Completed
Not Applicable
Ventricular Reversed Remodeling After LTX in PAH PatientsPulmonary Arterial Hypertension
NCT02391441University Medical Center Groningen17
Not yet recruiting
Not Applicable
Improvement in Right Heart Chambers Dimensions After Closure of The Hole in the Heart Chamber Partition WallHealth Condition 1: Q211- Atrial septal defect
CTRI/2024/04/065177AIIMS Delhi Research Section
Recruiting
Not Applicable
Prediction of left ventricular reverse remodeling by optimal medical therapy using T1 mapping in patients with non-ischemic cardiomyopathyonischemic dilated cardiomyopathy
JPRN-UMIN000033121Kanagawa Cardiovascular and Respiratory Center100